| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.53▼ | 2.52▼ | 2.52▼ | 2.53▼ | 2.52▼ |
| MA10 | 2.53▼ | 2.54▼ | 2.53▼ | 2.53▼ | 2.35▲ |
| MA20 | 2.54▼ | 2.52▼ | 2.52▲ | 2.52▲ | 3.08▼ |
| MA50 | 2.51▲ | 2.52▼ | 2.53▼ | 2.35▲ | 1.83▲ |
| MA100 | 2.52▼ | 2.52▲ | 2.51▲ | 3.27▼ | 1.98▲ |
| MA200 | 2.53▼ | 2.47▲ | 2.39▲ | 2.09▲ | 7.12▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.000▼ | 0.000▲ | 0.007▲ | -0.139▼ |
| RSI | 46.803▼ | 48.618▼ | 49.084▼ | 51.169▲ | 49.876▼ |
| STOCH | 23.214 | 28.571 | 41.587 | 69.723 | 46.864 |
| WILL %R | -85.714▼ | -85.714▼ | -54.545 | -34.097 | -79.202▼ |
| CCI | -49.943 | -42.523 | 6.364 | 42.564 | -21.687 |
|
Tuesday, April 21, 2026 09:43 PM
Detailed price information for Moleculin Biotech CS (MBRX-Q) from The Globe and Mail including charting and trades.
|
|
Tuesday, April 21, 2026 07:35 AM
Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that an abstract highlighting data on its lead drug candidate, annamycin, has been accepted for poster ...
|
|
Tuesday, March 17, 2026 06:06 AM
HOUSTON, March 17, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it will participate in a fireside chat at the 38th Annual ROTH ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/05/26 | 2.53 | 2.53 | 2.52 | 2.52 | 50,494 |
| 01/05/26 | 2.56 | 2.58 | 2.49 | 2.51 | 24,939 |
| 30/04/26 | 2.46 | 2.58 | 2.4598 | 2.56 | 67,060 |
| 29/04/26 | 2.56 | 2.56 | 2.45 | 2.51 | 74,970 |
| 28/04/26 | 2.56 | 2.624 | 2.50 | 2.56 | 132,629 |
| 27/04/26 | 2.55 | 2.56 | 2.4581 | 2.54 | 100,754 |
| 24/04/26 | 2.54 | 2.639 | 2.50 | 2.54 | 99,187 |
| 23/04/26 | 2.47 | 2.5791 | 2.29 | 2.54 | 544,260 |
| 22/04/26 | 2.54 | 2.54 | 2.42 | 2.50 | 57,865 |
| 21/04/26 | 2.57 | 2.5999 | 2.47 | 2.53 | 59,892 |
|
|
||||
|
|
||||
|
|